Dopavision closes EUR12m Series A Round
Dopavision, a company pioneering the development of digital therapeutics, has closed a EUR12 million Series A financing round. Seventure Partners led the round and was joined by Novartis Pharmaceuticals and the Company’s existing shareholders such as Boehringer Ingelheim Venture Fund and Ababax Health, significantly broadening the Company’s shareholder base of